期刊文献+

临床药师在干预万古霉素血药浓度监测的作用研究 被引量:10

Role of Chnical Pharmacist Intervention in Therapeutic Drug Monitoring of Vancomycin
下载PDF
导出
摘要 目的:研究临床药师在万古霉素血药浓度监测干预中的作用,为临床合理用药提供参考。方法对我院2011~2013年进行万古霉素血药浓度监测的患者进行分组:不达标组(浓度〈10μg·mL-1)、达标组(10~20μg·mL-1)、超过有效范围组(〉20μg·mL-1)。同时对临床药师的建议进行统计分析。结果不达标组:剂量增加比例为3%(3/35);达标组:剂量无调整比例91%(48/53);超过有效范围组:剂量减少比例为12.5%(3/24)。结论临床药师在对万古霉素血药浓度达标组的建议,临床医生采纳较高,对于未达标组和超过有效范围组,临床医生的采纳较低。临床药师加强与临床医生的合作,保证临床的安全、有效用药。 Objective To study the role of clinical pharmacists in serum vancomycin concentration monitoring, so as to provide references for rational use of drug service in clinical settings practice. Methods We collected the patients data with vancomycin concentration monitoring from 2011-2013. Based on the characteristics of these patients, we divided the samples into three groups:no-target group (concentration〈10 μg·mL-1), target group (10~20μg·mL-1), over-target group 〉20 μg·mL-1). Results The proportion of dose increase in the no-target group was 3%(3/35).The ratio of no dose adjustment in target group was 91%(48/53), but the ratio of dose reduction in over-target group accounts for 12.5% (3/24). Conclusion There was no statistics difference in three group. The clinicians seem to adopt pharmacist intervention in target group. Clinical pharmacists should cooperate with clinicians to ensure effective medication usage.
出处 《中国药物警戒》 2015年第7期439-441,443,共4页 Chinese Journal of Pharmacovigilance
关键词 万古霉素 干预 临床药师 vancomycin intervention clinical pharmacist
  • 相关文献

参考文献9

二级参考文献37

  • 1朱曼,郭代红,石莉,宁静,裴保香.2000-2004年我院4种抗癫痫药物血药浓度监测结果分析[J].药物流行病学杂志,2005,14(4):223-225. 被引量:3
  • 2Jusus Valle MJ, Lopez FG, Navarro AS. Development and vali- dation of an HPLC method for vancomycin application to a pharmacokinetic study[J]. J Pharm Biomed Anal,2008,48(3) : 835-839. 被引量:1
  • 3Rybak M, Lomaestro B, Rotschafer JC,et al. Therapeutic mo- nitoring of vancomycin in adult patients: a consensus review ofthe American Society of Health-System Pharmacists, the Infec- tious Diseases Society of America, and the Society of Infectious Diseases Pharmacists[J]. Am J Health-Syst Pharm,2009, 66 (1): 8298. 被引量:1
  • 4Bosso JA, Nappi J, Rudisill C, et al. Relationship between vancomycin trough coneentrations and nephrotoxicity: a pro- spective multicenter trial[J]. Antimierob Agents Chemother, 2011 : p. 5475-5479. 被引量:1
  • 5Lee-Such SC, Overholser BR, Munoz-Price LS. Nephrotoxiei- ty associated with aggressive vancomycin therapy. Paper pres- ented at 46th Interscienee Conerence on Antimicrobial Agents and Chemotherapy. San Francisco, CAr 2006 Sep. 被引量:1
  • 6Nguyen M, Wong J, Lee C et al. Nephrotoxicity associated with high dose vs standard dose vancomyein therapy. Paper presented at 47th Interseienee Conference on antimicrobial A- gents and Chemotherapy. Chicago, IL:2007 Sep. 被引量:1
  • 7Vance-Bryan K, Rotschafer JC, Gilliland SS, et al. A compar- ative assessment of vancomycin-assoeiated nephrotoxicity in the young versus the elderly hopitalized patient[J].J Ant imicrob Chemother, 1994, 33 : 811-821. 被引量:1
  • 8Lut z H, Lerz T, Weidauer H, et al. Ototoxicity of vancomy- cin I, experimental study in guinea pigs[J]. ORL, 1991, 53 (5) :273- 278. 被引量:1
  • 9Brummett R, Fox K, Jacobs F, et al. Augmented gentamicin ototoxicity induced by vancomycin in guinea pigs[J]. Arch Oto- laryngol Head Neck Surg, 1990,116(1 ) :61-64. 被引量:1
  • 10Tange RA, Kieviet HI, Marie iv, et al. An experimental study of vancomycin-induced cochlea damage[J]. Archi Otorhi- nolaryngol,1989, 246: 67-70. 被引量:1

共引文献314

同被引文献102

引证文献10

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部